Literature DB >> 20204696

CMV in moderately active colitis: much ado about nothing?

Alan C Moss.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20204696     DOI: 10.1007/s10620-010-1172-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  18 in total

1.  Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee.

Authors:  Asher Kornbluth; David B Sachar
Journal:  Am J Gastroenterol       Date:  2004-07       Impact factor: 10.864

Review 2.  Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander?

Authors:  Garrett Lawlor; Alan C Moss
Journal:  Inflamm Bowel Dis       Date:  2010-09       Impact factor: 5.325

3.  Outcome of cytomegalovirus infections in patients with inflammatory bowel disease.

Authors:  K A Papadakis; J K Tung; S W Binder; L Y Kam; M T Abreu; S R Targan; E A Vasiliauskas
Journal:  Am J Gastroenterol       Date:  2001-07       Impact factor: 10.864

4.  The role of CMV in steroid-resistant ulcerative colitis: A systematic review.

Authors:  Karyn Ayre; Bryan F Warren; Katie Jeffery; Simon P L Travis
Journal:  J Crohns Colitis       Date:  2009-04-14       Impact factor: 9.071

5.  Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines.

Authors:  C Söderberg-Nauclér; K N Fish; J A Nelson
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

6.  Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis.

Authors:  M Cottone; G Pietrosi; G Martorana; A Casà; G Pecoraro; L Oliva; A Orlando; M Rosselli; A Rizzo; L Pagliaro
Journal:  Am J Gastroenterol       Date:  2001-03       Impact factor: 10.864

7.  Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies.

Authors:  Takuya Yoshino; Hiroshi Nakase; Satoru Ueno; Norimitsu Uza; Satoko Inoue; Sakae Mikami; Minoru Matsuura; Katsuyuki Ohmori; Takaki Sakurai; Satoshi Nagayama; Suguru Hasegawa; Yoshiharu Sakai; Tsutomu Chiba
Journal:  Inflamm Bowel Dis       Date:  2007-12       Impact factor: 5.325

8.  Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study.

Authors:  Neeraja Kambham; Rohini Vij; Christine A Cartwright; Teri Longacre
Journal:  Am J Surg Pathol       Date:  2004-03       Impact factor: 6.394

9.  Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy.

Authors:  Valeria D'Ovidio; Piero Vernia; Giuseppe Gentile; Angela Capobianchi; Adriana Marcheggiano; Angelo Viscido; Pietro Martino; Renzo Caprilli
Journal:  J Clin Virol       Date:  2008-07-09       Impact factor: 3.168

10.  Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation.

Authors:  Thomas Widmann; Urban Sester; Barbara C Gärtner; Jörg Schubert; Michael Pfreundschuh; Hans Köhler; Martina Sester
Journal:  PLoS One       Date:  2008-11-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.